NOVEL TRICYCLIC COMPOUNDS

The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The comp...

Full description

Saved in:
Bibliographic Details
Main Authors DAWN M. GEORGE, BRYAN A. FIAMENGO, NEIL WISHART, DAVID J. CALDERWOOD, ERIC C. BREINLINGER, LU WANG, MICHAEL FRIEDMAN, ANNA M. ERICSSON, KELLY D. MULLEN, JEFFREY W. VOSS, ERIC R. GOEDKEN, GRIER A. WALLACE, GAGANDEEP SOMAL, MARIA A. ARGIRIADI, KENT D. STEWART, BIQIN C. LI, KRISTINE E. FRANK, NATHAN S. JOSEPHSOHN, MICHAEL J. MORYTKO, KEVIN R. WOLLER
Format Patent
LanguageEnglish
Spanish
Published 19.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. La invención proporciona un compuesto de Fórmula (la), (Ib), (Ic), (Id), (le), (If), (lg), (Ih), (Ii), (lj), (1k), o (II) como se define en la presente, sales farmacéuticamente aceptables, profármacos, metabilitos biológicamente activos, estereoisómeros e isómeros de los mismos en donde las variables son como se define en la presente. Los compuestos de la invención son útiles para tratar condiciones inmunológicas y oncológicas.
AbstractList The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. La invención proporciona un compuesto de Fórmula (la), (Ib), (Ic), (Id), (le), (If), (lg), (Ih), (Ii), (lj), (1k), o (II) como se define en la presente, sales farmacéuticamente aceptables, profármacos, metabilitos biológicamente activos, estereoisómeros e isómeros de los mismos en donde las variables son como se define en la presente. Los compuestos de la invención son útiles para tratar condiciones inmunológicas y oncológicas.
Author ERIC C. BREINLINGER
KELLY D. MULLEN
MARIA A. ARGIRIADI
DAWN M. GEORGE
GRIER A. WALLACE
LU WANG
BIQIN C. LI
JEFFREY W. VOSS
KRISTINE E. FRANK
ERIC R. GOEDKEN
NATHAN S. JOSEPHSOHN
ANNA M. ERICSSON
GAGANDEEP SOMAL
MICHAEL FRIEDMAN
NEIL WISHART
BRYAN A. FIAMENGO
KENT D. STEWART
MICHAEL J. MORYTKO
DAVID J. CALDERWOOD
KEVIN R. WOLLER
Author_xml – fullname: DAWN M. GEORGE
– fullname: BRYAN A. FIAMENGO
– fullname: NEIL WISHART
– fullname: DAVID J. CALDERWOOD
– fullname: ERIC C. BREINLINGER
– fullname: LU WANG
– fullname: MICHAEL FRIEDMAN
– fullname: ANNA M. ERICSSON
– fullname: KELLY D. MULLEN
– fullname: JEFFREY W. VOSS
– fullname: ERIC R. GOEDKEN
– fullname: GRIER A. WALLACE
– fullname: GAGANDEEP SOMAL
– fullname: MARIA A. ARGIRIADI
– fullname: KENT D. STEWART
– fullname: BIQIN C. LI
– fullname: KRISTINE E. FRANK
– fullname: NATHAN S. JOSEPHSOHN
– fullname: MICHAEL J. MORYTKO
– fullname: KEVIN R. WOLLER
BookMark eNrjYmDJy89L5WSQ9PMPc_VRCAnydI509vF0VnD29w3wD_VzCeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGhkYGBmbGFoaOxkQpAgA1fiJY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Forestry
Agriculture
DocumentTitleAlternate NUEVOS COMPUESTOS TRICICLICOS.
ExternalDocumentID MX2012006381A
GroupedDBID EVB
ID FETCH-epo_espacenet_MX2012006381A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:52:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MX2012006381A3
Notes Application Number: MX20120006381
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120619&DB=EPODOC&CC=MX&NR=2012006381A
ParticipantIDs epo_espacenet_MX2012006381A
PublicationCentury 2000
PublicationDate 20120619
PublicationDateYYYYMMDD 2012-06-19
PublicationDate_xml – month: 06
  year: 2012
  text: 20120619
  day: 19
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies ABBOTT LABORATORIES.
RelatedCompanies_xml – name: ABBOTT LABORATORIES.
Score 2.7241397
Snippet The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
TRAPPING
Title NOVEL TRICYCLIC COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120619&DB=EPODOC&locale=&CC=MX&NR=2012006381A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTS3TDIxMUrStUxKBA3dmADLQeNkI90k0zSjlBRTg1Rz8Al8vn5mHqEmXhGmEUwM2bC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2NAJWT5ZqLk62rgH-Lv7Oas7Otr4Ran5BEDlQ9WzoyMzACmxHm4Oyg2uYE2hbSgFyneImyMAWADQur0SIgSm1WJiB2zG9CHoORqowA6cz7CI2YQYO0PWZUKYvdCocyITmymIRBkk__zBXH4WQIE_nSGcfT2cFZ3_fAP9QP5dgUQYlN9cQZw9doOXxcK_G-0YgOdRYjIElLz8vVYJBwdAk0dzELMUixTg1zcTS0DjJwDTFJNU4MdXQzCIpJdVckkEaj0FSeGWlGbhAPND6J0NLGQaWkqLSVFlgTVuSJAcOIQCjYX4D
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gGtGTVo2Ij8aY3oi03VJ6aAxs2xTtg2Ah9US6dDHGpBBa4993txblxG2yk8w-km9md3YeAA-JbhCEFNI2SMJdN4jpQXWutIm2UNJU61C9rMDnB113gp5jLa7B5yYXpqwT-l0WR2SImjO8F6W-Xv07sawytjJ_JB9saPnkRKYlVa9jWWHmyZCsgWmPQivEEsamH0vB-JfHzbPc34N9dsfWORzs6YCnpay2bYpzAgcjJi4rTqFGcwGO--_rqg4GFaCBN43YBDjk7TMr0q--whlZoTI_g2YQTm1PjMZD_Ia9IRZx6I_CSWC9nsO9Y0fYbbPJZ39bnfnx1kLVC6hny4xegiijREfdtJeqdIEMWSUdLUVUTajc7ZGU6k1o7RB0tZN7Bw038r2ZNwxeWnDEOTwWSjauoV6sv-gNs7oFuS1P6we3Y4D2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+TRICYCLIC+COMPOUNDS&rft.inventor=DAWN+M.+GEORGE&rft.inventor=BRYAN+A.+FIAMENGO&rft.inventor=NEIL+WISHART&rft.inventor=DAVID+J.+CALDERWOOD&rft.inventor=ERIC+C.+BREINLINGER&rft.inventor=LU+WANG&rft.inventor=MICHAEL+FRIEDMAN&rft.inventor=ANNA+M.+ERICSSON&rft.inventor=KELLY+D.+MULLEN&rft.inventor=JEFFREY+W.+VOSS&rft.inventor=ERIC+R.+GOEDKEN&rft.inventor=GRIER+A.+WALLACE&rft.inventor=GAGANDEEP+SOMAL&rft.inventor=MARIA+A.+ARGIRIADI&rft.inventor=KENT+D.+STEWART&rft.inventor=BIQIN+C.+LI&rft.inventor=KRISTINE+E.+FRANK&rft.inventor=NATHAN+S.+JOSEPHSOHN&rft.inventor=MICHAEL+J.+MORYTKO&rft.inventor=KEVIN+R.+WOLLER&rft.date=2012-06-19&rft.externalDBID=A&rft.externalDocID=MX2012006381A